Back to search

Ireland· IE-PA-PA0776/002/001

Clopixol 200 mg/ml Solution for Injection

A zuclopenthixol product containing zuclopenthixol decanoate, registered in Ireland by Lundbeck ( Ireland ) Limited. The same ATC class is registered in 14 of our 19 countries.

ATC N05AF05

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedClopixol 200 mg/ml Solution for Injec…ATCN05AF05REGISTER NO.IE-PA-PA0776/002/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Zuclopenthixol is registered in 14 of 19 countries.

Countries holding a registration under ATC N05AF05 (zuclopenthixol), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 8 of them publish a price we can compare per daily dose

Zuclopenthixol · ATC N05AF05

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of zuclopenthixol costs, country by country.

Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Zuclopenthixol · price per daily dose (30 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.27
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
ZUCLOPENTHIXOL DECANOATE
Manufacturer
Lundbeck ( Ireland ) Limited
Country
Ireland (IE)
ATC code
N05AF05
ATC class
Zuclopenthixol
Defined daily dose
30 mg, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA0776/002/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

70 interactions on record for zuclopenthixol.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Zuclopenthixol · interactions on record

70 records

70 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Zuclopenthixol in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All zuclopenthixol products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Cisordinol Depot
  • Belgium · Clopixol Depot
  • Bulgaria · Клопиксол Депо
  • Cyprus · Clopixol Depot
  • Czechia · Cisordinol Depot
  • Germany · Ciatyl-Z Depot
  • Denmark · Cisordinol Depot
  • Estonia · Cisordinol Depot
  • Spain · Clopixol Depot
  • Finland · Cisordinol Depot
  • France · Clopixol Action Prolongee
  • United Kingdom (Northern Ireland) · Clopixol
  • Greece · Clopixol Depot
  • Hungary · Cisordinol Depot
  • Iceland · Cisordinol Depot
  • Italy · Clopixol
  • Lithuania · Cisordinol Depot
  • Luxembourg · Clopixol Depot
  • Latvia · Cisordinol Depot
  • Malta · Clopixol
  • Netherlands · Cisordinol Depot
  • Norway · Cisordinol Depot
  • Poland · Clopixol Depot
  • Portugal · Cisordinol Depot
  • Romania · Clopixol Depot
  • Sweden · Cisordinol Depot
  • Slovenia · Clopixol Depot
  • Slovakia · Cisordinol Depot

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/11e0bb96-7f3f-4090-a60d-adc68c36c44f
GET /v1/drugs/11e0bb96-7f3f-4090-a60d-adc68c36c44f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "routes": [
    "Subcutaneous use"
  ],
  "source": "hpra",
  "atc_all": [
    "N05AF",
    "N05AF05"
  ],
  "strength": null,
  "pa_number": "PA0776/002/001",
  "substances": [
    "ZUCLOPENTHIXOL DECANOATE"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "13/06/1977",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about zuclopenthixol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.